Engineered cardiac patches from hiPSC-derived cardiomyocytes
Jonas Jawad, Mohammad Z. Khan, Tamer Jabsheh, Daryoush Javidi · 2026
Read Engineered cardiac patches from hiPSC-derived cardiomyocytes by Jonas Jawad, Mohammad Z. Khan, Tamer Jabsheh, Daryoush Javidi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13312731.txt.
Description
Jonas Jawad and co-authors review heart patches grown from reprogrammed stem cells in a 2026 paper. Heart failure follows when muscle dies and the heart cannot regrow it well. Patches of lab-grown heart cells on scaffolds could lay fresh muscle on the scar, unlike loose cell shots.
The review spans rodent, pig, and primate work plus first human trials through early 2025. Patches lived on, linked up, and lifted heart output in large animals, with lower rhythm risk than cell shots. Early human use proved safe, with hints of gain. Immune clash, cell maturity, and mass output still block wide use.
Catalog record
| CREATOR | Jonas Jawad, Mohammad Z. Khan, Tamer Jabsheh, Daryoush Javidi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |